Radiation Dose Management Market - A Global and Regional Analysis: Focus on Product, Modality, Mode of Deployment, Application, End User, and Country Analysis - Analysis and Forecast, 2025-2035
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
This report will be delivered in 7-10 working days.Global Radiation Dose Management Market: Industry Overview
The global radiation dose management market was valued at $XX million in 2024, and it is expected to grow at a CAGR of 10.45% and reach $XX million by 2035. The growth in the global radiation dose management market is expected to be driven by the rising prevalence of chronic disorders requiring diagnostic intervention, the growing focus on interventional radiology (IR), and the growing awareness surrounding patient safety and the harmful and biological effects of overexposure to ionizing radiation.
Market Lifecycle Stage
The radiation dose management market is in the developing phase. The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players.
Market Segmentation:
Segmentation 1: by Modality
Segmentation 2: by Product
Segmentation 3: by Mode of Deployment
Segmentation 4: by Application
Segmentation 5: by End User
Segmentation 6: by Region
Following are the drivers for the global radiation dose management market:
Product/Innovation Strategy: The product segment helps the reader understand the different types of radiation dose management software available for use in hospitals and diagnostic centers. Moreover, the study provides the reader with a detailed understanding of the different radiation dose products based on the modalities they are compatible with (CT scanners, X-Ray, CR, and DR, mammography system, interventional angiography systems/angio CT, fluoroscopy systems, PET scanners and SPECT, and hybrid imaging), the modes on which they can be deployed (cloud-based, web-based, and on-premises), and the end users who can adopt such software (hospitals, diagnostic centers, and others).
Growth/Marketing Strategy: The global radiation dose management market has seen developments by key players operating in the market, such as partnerships, collaborations and business expansions, and new product launches. Partnerships accounted for the maximum number of key developments, i.e., nearly 70.00% of the total developments in the global radiation dose management market.
Competitive Strategy: Key players in the global radiation dose management market analyzed and profiled in the study involve players that offer radiation dose software. Moreover, a detailed market share analysis of the players operating in the global radiation dose management market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
Some of the key players in this market are:
This report will be delivered in 7-10 working days.Global Radiation Dose Management Market: Industry Overview
The global radiation dose management market was valued at $XX million in 2024, and it is expected to grow at a CAGR of 10.45% and reach $XX million by 2035. The growth in the global radiation dose management market is expected to be driven by the rising prevalence of chronic disorders requiring diagnostic intervention, the growing focus on interventional radiology (IR), and the growing awareness surrounding patient safety and the harmful and biological effects of overexposure to ionizing radiation.
Market Lifecycle Stage
The radiation dose management market is in the developing phase. The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players.
Market Segmentation:
Segmentation 1: by Modality
- CT Scanners
- X-Ray, CR, and DR
- Mammography Systems
- Interventional Angiography Systems/Angio CT
- Fluoroscopy Systems
- PET Scanners and SPECT
- Hybrid Imaging
Segmentation 2: by Product
- Radimetrics Enterprise Platform
- DoseWatch and DoseWatch Explore
- teamplay Dose
- NEXO [DOSE]
- tqm/Dose and DoseMonitor
- Radiation Dose Monitor
- Imalogix Platform
- Syncro-Dose
- NovaDose
- DoseWise Portal
- SafeCT
- MyXrayDose
- DoseM
- Dose Tracking System
- DoseTrack
Segmentation 3: by Mode of Deployment
- Web-Based
- On-Premise
- Cloud-Based
Segmentation 4: by Application
- Oncology
- Cardiology
- Orthopedic
- Other Application
Segmentation 5: by End User
- Hospitals
- Diagnostic Centers
- Others
Segmentation 6: by Region
- North America- U.S. and Canada
- Europe- Germany, France, U.K., Italy, Spain, Netherlands, and Rest-of-Europe
- Asia-Pacific- Japan, China, India, Australia and New Zealand, South Korea, and Rest-of-Asia-Pacific
- Latin America- Brazil, Mexico, and Rest-of-Latin America
- Middle East and Africa
- In December 2020, Bayer AG launched Radimetrics v3.0, the latest evolution of its enterprise dose management utility.
- In December 2020, FUJIFILM Holdings Corporation launched the unique SYNAPSE Dose 2.0 to provide a comprehensive system for managing patient radiation exposure across several imaging modalities.
- In January 2020, Agfa HealthCare collaborated with Maasstad Hospital in the Netherlands to support advancements in the consistency and optimization of radiation doses.
- In April 2019, Qaelum NV signed an agreement with TOYO Corporation to distribute its dose monitoring solution, DOSE, in Japan.
- In January 2019, SST Group, Inc. partnered with Intermountain Healthcare to implement a software platform for the Radiation Dose Monitor (RDM). The software platform permits medical professionals to manage, examine, and optimize the dose delivered to a patient during interventional procedures, medical imaging examinations, and image-guided surgery.
- In August 2018, Imalogix launched a newer version of its radiation dose management platform with additional fluoroscopy capabilities. The software solution can automatically calculate the peak skin dose for the patient during a fluoroscopic procedure.
- In August 2018, Guerbet LLC USA, a subsidiary of the Guerbet Group, partnered with Imalogix to decrease inconsistency and advance the quality, safety, and competence of care around radiation dose management, to enable the network health system and member facilities to monitor patient radiation dose on a per-procedure and cumulative basis.
- In March 2018, PACSHealth, LLC launched DoseMonitor, a radiation dose management software for tracking radiation dose absorption.
Following are the drivers for the global radiation dose management market:
- Increasing installed bases of radiology equipment and the number of scans lead to a higher risk of radiation exposure, thus creating demand for dose management solutions.
- The increasing prevalence of cardiovascular diseases and growing occupational hazards in cath labs lead to the growing concern surrounding the effects of radiation exposure.
- Growing focus on interventional radiology (IR) is expected to increase demand for IR imaging systems and subsequently lead to a higher risk of radiation exposure.
- Increasing concern related to radiation overexposure is leading to higher adoption of dose management solutions.
- Growing awareness and initiatives for radiation dose management are expected to push the adoption of dose management software.
- Advancements in dose optimization and benchmarking in various countries will encourage healthcare institutions to adopt dose management software.
- The lack of awareness among the population and the shortage of skilled and trained professionals leading to a steep learning curve hinders the adoption of dose management software.
- The lack of diagnostic reference levels (DRLs) for radiation dose benchmarking in low-income countries causes healthcare institutions to not pursue the adoption of dose management software with vigor.
Product/Innovation Strategy: The product segment helps the reader understand the different types of radiation dose management software available for use in hospitals and diagnostic centers. Moreover, the study provides the reader with a detailed understanding of the different radiation dose products based on the modalities they are compatible with (CT scanners, X-Ray, CR, and DR, mammography system, interventional angiography systems/angio CT, fluoroscopy systems, PET scanners and SPECT, and hybrid imaging), the modes on which they can be deployed (cloud-based, web-based, and on-premises), and the end users who can adopt such software (hospitals, diagnostic centers, and others).
Growth/Marketing Strategy: The global radiation dose management market has seen developments by key players operating in the market, such as partnerships, collaborations and business expansions, and new product launches. Partnerships accounted for the maximum number of key developments, i.e., nearly 70.00% of the total developments in the global radiation dose management market.
Competitive Strategy: Key players in the global radiation dose management market analyzed and profiled in the study involve players that offer radiation dose software. Moreover, a detailed market share analysis of the players operating in the global radiation dose management market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
Some of the key players in this market are:
- Agfa-Gevaert Group
- Sectra AB
- Bracco
- Guerbet
- Canon Inc.
- General Electric Company
- FUJIFILM Holdings Corporation
- Imalogix
- Infinitt Healthcare Co. Ltd.
- Koninklijke Philips N.V.
- Medic Vision Imaging Solutions Ltd.
- Medsquare
- MyXrayDose Ltd.
- PACSHealth, LLC
- Qaelum NV
- Bayer AG
- SST Group Inc.
- Siemens Healthineers AG
Executive Summary
Scope and Definition
Market/Product Definition
Inclusion and Exclusion
Key Questions Answered
Analysis and Forecast Note
Research Methodology
1. MARKET OVERVIEW
1.1 Overview
1.1.1 Natural Radiation Sources
1.1.2 Biological Effects of Radiation
1.1.3 Usage of Radiation in Medical Devices
1.1.4 Radiation Dose
1.1.5 Effective Radiation Dose
1.1.6 Factors Contributing to Unnecessary Radiation Exposure
1.1.7 Radiation Exposure Trend
1.2 Key Trends
1.3 Opportunity Assessment
1.4 Patent Analysis
1.5 Comparative Analysis
1.6 Market Gap Analysis
1.7 Pricing Analysis
1.8 Change in Competitive Landscape and Product Demand
2. MARKET DYNAMICS
2.1 Overview
2.1.1 Impact Analysis
2.2 Market Drivers
2.3 Market Restraints
2.4 Market Opportunities
3. GLOBAL RADIATION DOSE MANAGEMENT MARKET: COMPETITIVE LANDSCAPE
3.1 Overview
3.2 Corporate Strategies
3.2.1 Mergers and Acquisitions
3.2.2 Synergistic Activities
3.2.3 Business Expansions and Funding
3.3 Business Strategies
3.3.1 Product Launches and Approvals
3.3.2 Publications
3.3.3 Licenses and Agreements
3.3.4 Other Activities
3.4 Market Share Analysis
4. GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY MODALITY), VALUE ($MILLION), 2023-2035
4.1 Overview
4.2 CT Scanners
4.3 X-Ray, CR, and DR
4.4 Mammography Systems
4.5 Interventional Angiography Systems/Angio CT
4.6 Fluoroscopy Systems
4.7 PET Scanners and SPECT
4.8 Hybrid Imaging
5. GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY PRODUCT), VALUE ($MILLION), 2023-2035
5.1 Overview
5.2 Radimetrics Enterprise Platform
5.2.1 Key Features
5.2.2 Radimetrics Enterprise Platform- Global Market
5.2.3 Installed Base
5.2.4 Compatible Modalities
5.2.5 Competitive Benchmarking
5.3 DoseWatch and DoseWatch Explore
5.3.1 Key Features
5.3.2 DoseWatch and DoseWatch Explore- Global Market
5.3.3 Installed Base
5.3.4 Compatible Modalities
5.3.5 Competitive Benchmarking
5.4 teamplay Dose
5.4.1 Key Features
5.4.2 teamplay Dose- Global Market
5.4.3 Installed Base
5.4.4 Compatible Modalities
5.4.5 Competitive Benchmarking
5.5 NEXO [DOSE]
5.5.1 Key Features
5.5.2 NEXO [DOSE]- Global Market
5.5.3 Installed Base
5.5.4 Compatible Modalities
5.5.5 Competitive Benchmarking
5.6 tqm/Dose and DoseMonitor
5.6.1 Key Features
5.6.2 tqm/Dose and DoseMonitor- Global Market
5.6.3 Installed Base
5.6.4 Compatible Modalities
5.6.5 Competitive Benchmarking
5.7 Radiation Dose Monitor
5.7.1 Key Features
5.7.2 Radiation Dose Monitor- Global Market
5.7.3 Installed Base
5.7.4 Compatible Modalities
5.7.5 Competitive Benchmarking
5.8 Imalogix Platform
5.8.1 Key Features
5.8.2 Imalogix Platform- Global Market
5.8.3 Installed Base
5.8.4 Compatible Modalities
5.8.5 Competitive Benchmarking
5.9 Syncro-Dose
5.9.1 Key Features
5.9.2 Syncro-Dose- Global Market
5.9.3 Installed Base
5.9.4 Compatible Modalities
5.9.5 Competitive Benchmarking
5.10 NovaDose
5.10.1 Key Features
5.10.2 NovaDose- Global Market
5.10.3 Installed Base
5.10.4 Compatible Modalities
5.10.5 Competitive Benchmarking
5.11 DoseWise Portal
5.11.1 Key Features
5.11.2 DoseWise Portal- Global Market
5.11.3 Installed Base
5.11.4 Compatible Modalities
5.11.5 Competitive Benchmarking
5.12 SafeCT
5.12.1 Key Features
5.12.2 SafeCT- Global Market
5.12.3 Installed Base
5.12.4 Compatible Modalities
5.12.5 Competitive Benchmarking
5.13 MyXrayDose
5.13.1 Key Features
5.13.2 MyXrayDose- Global Market
5.13.3 Installed Base
5.13.4 Compatible Modalities
5.13.5 Competitive Benchmarking
5.14 DoseM
5.14.1 Key Features
5.14.2 DoseM- Global Market
5.14.3 Installed Base
5.14.4 Compatible Modalities
5.14.5 Competitive Benchmarking
5.15 Dose Tracking System
5.15.1 Key Features
5.15.2 Dose Tracking System- Global Market
5.15.3 Installed Base
5.15.4 Compatible Modalities
5.15.5 Competitive Benchmarking
5.16 DoseTrack
5.16.1 Key Features
5.16.2 DoseTrack- Global Market
5.16.3 Installed Base
5.16.4 Compatible Modalities
5.16.5 Competitive Benchmarking
6. GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY MODE OF DEPLOYMENT), VALUE ($MILLION), 2023-2035
6.1 Overview
6.2 Web-Based
6.3 On-Premises
6.4 Cloud Based
7. GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY APPLICATION), VALUE ($MILLION), 2023-2035
7.1 Overview
7.2 Oncology
7.3 Cardiology
7.4 Orthopaedics
7.5 Other Applications
8. GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY END USER), VALUE ($MILLION), 2023-2035
8.1 Overview
8.2 Hospitals
8.3 Diagnostic Centers
8.4 Others
9. GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY REGION), VALUE ($MILLION), 2023-2035
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K
9.3.4 Italy
9.3.5 Spain
9.3.6 Netherlands
9.3.7 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia & New Zeland
9.4.5 South Korea
9.4.6 Rest-of-Asia-Pacific (RoAPAC)
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest-of-Latin America
9.6 Middle East and Africa
9.6.1 Middle East
9.6.2 Africa
10. COMPANY PROFILES
10.1 Agfa-Gevaert Group
10.1.1 Company Overview
10.1.2 Product Portfolio
10.1.3 Target Customers/ End Users
10.1.4 Analyst View
10.2 Bracco
10.2.1 Company Overview
10.2.2 Product Portfolio
10.2.3 Target Customers/ End Users
10.2.4 Analyst View
10.3 Bayer AG
10.3.1 Company Overview
10.3.2 Product Portfolio
10.3.3 Target Customers/ End Users
10.3.4 Analyst View
10.4 Canon Inc.
10.4.1 Company Overview
10.4.2 Product Portfolio
10.4.3 Target Customers/ End Users
10.4.4 Analyst View
10.5 FUJIFILM Holdings Corporation
10.5.1 Company Overview
10.5.2 Product Portfolio
10.5.3 Target Customers/ End Users
10.5.4 Analyst View
10.6 Guerbet
10.6.1 Company Overview
10.6.2 Product Portfolio
10.6.3 Target Customers/ End Users
10.6.4 Analyst View
10.7 General Electric Company
10.7.1 Company Overview
10.7.2 Product Portfolio
10.7.3 Target Customers/ End Users
10.7.4 Analyst View
10.8 Imalogix
10.8.1 Company Overview
10.8.2 Product Portfolio
10.8.3 Target Customers/ End Users
10.8.4 Analyst View
10.9 Infinitt Healthcare Co., Ltd.
10.9.1 Company Overview
10.9.2 Product Portfolio
10.9.3 Target Customers/ End Users
10.9.4 Analyst View
10.10 LANDAUER
10.10.1 Company Overview
10.10.2 Product Portfolio
10.10.3 Target Customers/ End Users
10.10.4 Analyst View
10.11 Medsquare
10.11.1 Company Overview
10.11.2 Product Portfolio
10.11.3 Target Customers/ End Users
10.11.4 Analyst View
10.12 Medic Vision Imaging Solutions Ltd.
10.12.1 Company Overview
10.12.2 Product Portfolio
10.12.3 Target Customers/ End Users
10.12.4 Analyst View
10.13 MyXrayDose Ltd.
10.13.1 Company Overview
10.13.2 Product Portfolio
10.13.3 Target Customers/ End Users
10.13.4 Analyst View
10.14 Novarad Corporation
10.14.1 Company Overview
10.14.2 Product Portfolio
10.14.3 Target Customers/ End Users
10.14.4 Analyst View
10.15 PACSHealth, LLC
10.15.1 Company Overview
10.15.2 Product Portfolio
10.15.3 Target Customers/ End Users
10.15.4 Analyst View
10.16 Qaelum NV
10.16.1 Company Overview
10.16.2 Product Portfolio
10.16.3 Target Customers/ End Users
10.16.4 Analyst View
10.17 Sectra AB
10.17.1 Company Overview
10.17.2 Product Portfolio
10.17.3 Target Customers/ End Users
10.17.4 Analyst View
10.18 SST Group Inc.
10.18.1 Company Overview
10.18.2 Product Portfolio
10.18.3 Target Customers/ End Users
10.18.4 Analyst View
10.19 Siemens Healthineers AG
10.19.1 Company Overview
10.19.2 Product Portfolio
10.19.3 Target Customers/ End Users
10.19.4 Analyst View
10.20 Virtual Phantoms Inc.
10.20.1 Company Overview
10.20.2 Product Portfolio
10.20.3 Target Customers/ End Users
10.20.4 Analyst View
Scope and Definition
Market/Product Definition
Inclusion and Exclusion
Key Questions Answered
Analysis and Forecast Note
Research Methodology
1. MARKET OVERVIEW
1.1 Overview
1.1.1 Natural Radiation Sources
1.1.2 Biological Effects of Radiation
1.1.3 Usage of Radiation in Medical Devices
1.1.4 Radiation Dose
1.1.5 Effective Radiation Dose
1.1.6 Factors Contributing to Unnecessary Radiation Exposure
1.1.7 Radiation Exposure Trend
1.2 Key Trends
1.3 Opportunity Assessment
1.4 Patent Analysis
1.5 Comparative Analysis
1.6 Market Gap Analysis
1.7 Pricing Analysis
1.8 Change in Competitive Landscape and Product Demand
2. MARKET DYNAMICS
2.1 Overview
2.1.1 Impact Analysis
2.2 Market Drivers
2.3 Market Restraints
2.4 Market Opportunities
3. GLOBAL RADIATION DOSE MANAGEMENT MARKET: COMPETITIVE LANDSCAPE
3.1 Overview
3.2 Corporate Strategies
3.2.1 Mergers and Acquisitions
3.2.2 Synergistic Activities
3.2.3 Business Expansions and Funding
3.3 Business Strategies
3.3.1 Product Launches and Approvals
3.3.2 Publications
3.3.3 Licenses and Agreements
3.3.4 Other Activities
3.4 Market Share Analysis
4. GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY MODALITY), VALUE ($MILLION), 2023-2035
4.1 Overview
4.2 CT Scanners
4.3 X-Ray, CR, and DR
4.4 Mammography Systems
4.5 Interventional Angiography Systems/Angio CT
4.6 Fluoroscopy Systems
4.7 PET Scanners and SPECT
4.8 Hybrid Imaging
5. GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY PRODUCT), VALUE ($MILLION), 2023-2035
5.1 Overview
5.2 Radimetrics Enterprise Platform
5.2.1 Key Features
5.2.2 Radimetrics Enterprise Platform- Global Market
5.2.3 Installed Base
5.2.4 Compatible Modalities
5.2.5 Competitive Benchmarking
5.3 DoseWatch and DoseWatch Explore
5.3.1 Key Features
5.3.2 DoseWatch and DoseWatch Explore- Global Market
5.3.3 Installed Base
5.3.4 Compatible Modalities
5.3.5 Competitive Benchmarking
5.4 teamplay Dose
5.4.1 Key Features
5.4.2 teamplay Dose- Global Market
5.4.3 Installed Base
5.4.4 Compatible Modalities
5.4.5 Competitive Benchmarking
5.5 NEXO [DOSE]
5.5.1 Key Features
5.5.2 NEXO [DOSE]- Global Market
5.5.3 Installed Base
5.5.4 Compatible Modalities
5.5.5 Competitive Benchmarking
5.6 tqm/Dose and DoseMonitor
5.6.1 Key Features
5.6.2 tqm/Dose and DoseMonitor- Global Market
5.6.3 Installed Base
5.6.4 Compatible Modalities
5.6.5 Competitive Benchmarking
5.7 Radiation Dose Monitor
5.7.1 Key Features
5.7.2 Radiation Dose Monitor- Global Market
5.7.3 Installed Base
5.7.4 Compatible Modalities
5.7.5 Competitive Benchmarking
5.8 Imalogix Platform
5.8.1 Key Features
5.8.2 Imalogix Platform- Global Market
5.8.3 Installed Base
5.8.4 Compatible Modalities
5.8.5 Competitive Benchmarking
5.9 Syncro-Dose
5.9.1 Key Features
5.9.2 Syncro-Dose- Global Market
5.9.3 Installed Base
5.9.4 Compatible Modalities
5.9.5 Competitive Benchmarking
5.10 NovaDose
5.10.1 Key Features
5.10.2 NovaDose- Global Market
5.10.3 Installed Base
5.10.4 Compatible Modalities
5.10.5 Competitive Benchmarking
5.11 DoseWise Portal
5.11.1 Key Features
5.11.2 DoseWise Portal- Global Market
5.11.3 Installed Base
5.11.4 Compatible Modalities
5.11.5 Competitive Benchmarking
5.12 SafeCT
5.12.1 Key Features
5.12.2 SafeCT- Global Market
5.12.3 Installed Base
5.12.4 Compatible Modalities
5.12.5 Competitive Benchmarking
5.13 MyXrayDose
5.13.1 Key Features
5.13.2 MyXrayDose- Global Market
5.13.3 Installed Base
5.13.4 Compatible Modalities
5.13.5 Competitive Benchmarking
5.14 DoseM
5.14.1 Key Features
5.14.2 DoseM- Global Market
5.14.3 Installed Base
5.14.4 Compatible Modalities
5.14.5 Competitive Benchmarking
5.15 Dose Tracking System
5.15.1 Key Features
5.15.2 Dose Tracking System- Global Market
5.15.3 Installed Base
5.15.4 Compatible Modalities
5.15.5 Competitive Benchmarking
5.16 DoseTrack
5.16.1 Key Features
5.16.2 DoseTrack- Global Market
5.16.3 Installed Base
5.16.4 Compatible Modalities
5.16.5 Competitive Benchmarking
6. GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY MODE OF DEPLOYMENT), VALUE ($MILLION), 2023-2035
6.1 Overview
6.2 Web-Based
6.3 On-Premises
6.4 Cloud Based
7. GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY APPLICATION), VALUE ($MILLION), 2023-2035
7.1 Overview
7.2 Oncology
7.3 Cardiology
7.4 Orthopaedics
7.5 Other Applications
8. GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY END USER), VALUE ($MILLION), 2023-2035
8.1 Overview
8.2 Hospitals
8.3 Diagnostic Centers
8.4 Others
9. GLOBAL RADIATION DOSE MANAGEMENT MARKET (BY REGION), VALUE ($MILLION), 2023-2035
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K
9.3.4 Italy
9.3.5 Spain
9.3.6 Netherlands
9.3.7 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia & New Zeland
9.4.5 South Korea
9.4.6 Rest-of-Asia-Pacific (RoAPAC)
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest-of-Latin America
9.6 Middle East and Africa
9.6.1 Middle East
9.6.2 Africa
10. COMPANY PROFILES
10.1 Agfa-Gevaert Group
10.1.1 Company Overview
10.1.2 Product Portfolio
10.1.3 Target Customers/ End Users
10.1.4 Analyst View
10.2 Bracco
10.2.1 Company Overview
10.2.2 Product Portfolio
10.2.3 Target Customers/ End Users
10.2.4 Analyst View
10.3 Bayer AG
10.3.1 Company Overview
10.3.2 Product Portfolio
10.3.3 Target Customers/ End Users
10.3.4 Analyst View
10.4 Canon Inc.
10.4.1 Company Overview
10.4.2 Product Portfolio
10.4.3 Target Customers/ End Users
10.4.4 Analyst View
10.5 FUJIFILM Holdings Corporation
10.5.1 Company Overview
10.5.2 Product Portfolio
10.5.3 Target Customers/ End Users
10.5.4 Analyst View
10.6 Guerbet
10.6.1 Company Overview
10.6.2 Product Portfolio
10.6.3 Target Customers/ End Users
10.6.4 Analyst View
10.7 General Electric Company
10.7.1 Company Overview
10.7.2 Product Portfolio
10.7.3 Target Customers/ End Users
10.7.4 Analyst View
10.8 Imalogix
10.8.1 Company Overview
10.8.2 Product Portfolio
10.8.3 Target Customers/ End Users
10.8.4 Analyst View
10.9 Infinitt Healthcare Co., Ltd.
10.9.1 Company Overview
10.9.2 Product Portfolio
10.9.3 Target Customers/ End Users
10.9.4 Analyst View
10.10 LANDAUER
10.10.1 Company Overview
10.10.2 Product Portfolio
10.10.3 Target Customers/ End Users
10.10.4 Analyst View
10.11 Medsquare
10.11.1 Company Overview
10.11.2 Product Portfolio
10.11.3 Target Customers/ End Users
10.11.4 Analyst View
10.12 Medic Vision Imaging Solutions Ltd.
10.12.1 Company Overview
10.12.2 Product Portfolio
10.12.3 Target Customers/ End Users
10.12.4 Analyst View
10.13 MyXrayDose Ltd.
10.13.1 Company Overview
10.13.2 Product Portfolio
10.13.3 Target Customers/ End Users
10.13.4 Analyst View
10.14 Novarad Corporation
10.14.1 Company Overview
10.14.2 Product Portfolio
10.14.3 Target Customers/ End Users
10.14.4 Analyst View
10.15 PACSHealth, LLC
10.15.1 Company Overview
10.15.2 Product Portfolio
10.15.3 Target Customers/ End Users
10.15.4 Analyst View
10.16 Qaelum NV
10.16.1 Company Overview
10.16.2 Product Portfolio
10.16.3 Target Customers/ End Users
10.16.4 Analyst View
10.17 Sectra AB
10.17.1 Company Overview
10.17.2 Product Portfolio
10.17.3 Target Customers/ End Users
10.17.4 Analyst View
10.18 SST Group Inc.
10.18.1 Company Overview
10.18.2 Product Portfolio
10.18.3 Target Customers/ End Users
10.18.4 Analyst View
10.19 Siemens Healthineers AG
10.19.1 Company Overview
10.19.2 Product Portfolio
10.19.3 Target Customers/ End Users
10.19.4 Analyst View
10.20 Virtual Phantoms Inc.
10.20.1 Company Overview
10.20.2 Product Portfolio
10.20.3 Target Customers/ End Users
10.20.4 Analyst View
